This is the authors' abstract. We don't add key points for this paper.
The recent global emphasis on prevention, diagnosis, and treatment of noncommunicable diseases is driving interest in better ways to increase and improve access to cancer care. Pathology is, of course, one of the cornerstones of cancer care: accurate diagnosis guides treatment, research, epidemiology, prevention, and public policy. Although access to quality pathology services is taken for granted in high-income countries, in low- and middle-income countries (LMIC), there is a sobering lack of access to these services. Data collected in sub-Saharan Africa, for example, show that a small number of countries have no access to pathology services, the majority have one pathologist per million population (compared with one pathologist per 20,000 population in the United States and United Kingdom), and even in the most developed regions, the number of pathologists is a fraction of that in high-income countries.1 There are far fewer trainees in pathology in all of Africa than there are in the United States. This inequity will only grow as the population doubles on that continent during the next few decades. As a result, the ratio of pathologists per population will only decline further over the upcoming years. Moreover, although the attrition rate is not known for most countries or regions, even if there were no attrition, the current rate of training would require 400 years to reach the number of pathologists per population as currently exists in the United States or United Kingdom. Clearly, this is not acceptable. All of this is set against a time when populations and policy makers should be demanding better access to health services in general and diagnostic pathology services in particular to provide high-quality care. Economic growth is occurring at an unprecedented rate, populations are growing, the middle class is growing in many regions, and urbanization enables populations to seek care previously unavailable in rural areas. Urban middle-class populations have higher expectations for access to health care. At the same time, increases in longevity mean that chronic diseases will become more prevalent, health care will be required for more years per person, and urbanization is associated with increased exposure to risk factors for noncommunicable diseases (eg, air pollution and tobacco use). The outcome is obvious: there will be increased demand for all health care services, especially those needed to address the growing problem of noncommunicable diseases. Because of the complexity of providing cancer care, it is in many ways the most pressing concern. It is a daunting problem and one that demands immediate and sustained action. What is to be done? Although it risks oversimplification, perhaps the single most important driver of long-term success is the concept of sustainability: if one always builds toward sustainability as part of a project or a program, then it quickly moves one away from the all-too-common one-off projects, self-serving research programs, and the “go-it-alone” approach that is the rule and not the exception for too many capacity-building efforts in LMICs. Building toward sustainability also forces one to design projects and programs that from the outset have a better design and structure. Part of sustainability, of course, is planned obsolescence: the goal should always be to make one’s project, one’s program, and one’s self irrelevant and no longer needed in the shortest possible time. Local populations must own and control their health care delivery systems. Another driver of success is the need for collaboration and partnership. These terms may feel hackneyed at times, but it is a certainty that without collaboration and partnership, nothing can be achieved except on the smallest scale. The problems facing global cancer care are enormous, will take many years to solve, and will require the careful integration of many disciplines, both medical and nonmedical. No single person, group, or organization has all of the knowledge, resources, or expertise to succeed by working alone. For those of us used to working in medicine, where a premium is placed on being able to work independently, it requires not a little change in thinking to make this transition. Some are more successful than others. But confronting the enormous challenges in global cancer care no longer is possible without a new approach: integration of medical disciplines, public-private partnerships, novel approaches to care using different care delivery models, and a relentless focus on using the most cost-effective and evidence-based approaches. All of this requires close collaboration and the formation of new types of partnerships. The era of turf battles needs to end. A fourth driver of success is realism. Not only are the scope and scale of the problem enormous, but the resources needed will always and forever be inadequate. It also is a long-term effort that will require patience, perseverance, and the ability to overcome obstacles and setbacks. Resource limitation will force judicious and pragmatic allocation of resources. Systems will be needed to detect and mitigate if not eliminate waste. Digressions that may be of interest but do not move projects or programs forward will need to be avoided or eliminated should they occur. Those involved in these efforts need to be realistic: there is a job that needs to be done, and it needs to be done as quickly and as efficiently as possible. Good intentions are nice but generally do not move projects or programs forward. A final driver of success is innovation and visionary thinking. We very much need new solutions to the many long-standing problems facing health care delivery in LMICs. These include novel ways of providing access to care, such as the recent telepathology initiative developed by the American Society for Clinical Pathology (ASCP) and spearheaded through the White House Office of Science and Technology Policy. In partnership with other organizations, including Paul Farmer’s organization—Partners in Health—the initiative is designed to provide access to automated histopathology and telepathology services crowd-sourced to the members of the ASCP for areas throughout Africa where diagnostics are unavailable and where it can be integrated with cancer treatment programs, either those that currently exist or those that can now be built as a result of providing diagnostics. The initiative will include programs for assessing program effectiveness and for bioethical considerations.2 Among the new visions for the future is a framework for developing sustainable approaches to capacity building described last year in the American Journal of Clinical Pathology in the call to action from the group African Strategies for Advancing Pathology.3 This includes strategic planning on a scale not previously used for capacity building in diagnostic pathology services. Yet another example of a driver for success is the commitment from the Center for Global Health at the National Cancer Institute to create research programs that help integrate the many facets of cancer diagnosis and treatment in LMICs, including pathology. It should come as no surprise that the three entities just described are collaborating in their efforts. Past approaches to providing aid or for capacity building in LMICs have been, with a few notable exceptions, ineffective and a waste of resources. Lessons can and have been learned from the failures as well as the successes. For the first time, there is reason for optimism that a new era is beginning, one that will take us to a point where the concept of global health no longer means aid and capacity building but rather means in the most literal sense global health.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Michael L. Wilson (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: